, /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: ) today announced results for its fourth quarter and its fiscal year ended . Sales during the fourth quarter of fiscal year 2024 were , an increase of 5% compared to sales of from the prior year's fourth quarter. Pre-tax earnings for the quarter were compared to for the prior year quarter.
Net earnings for the quarter were compared to net earnings of for the prior year quarter. Diluted earnings per share was compared to diluted earnings per share of in the prior year quarter. EBITDA for the quarter was compared to for the prior year quarter.
During the fourth quarter of the fiscal year, two non-recurring transactions were recorded that impacted reported earnings and EBITDA which management believes should be considered when analyzing our financial results. A detailed discussion of these transactions is included in the Corporate segment commentary below. Excluding the two non-recurring transactions, adjusted pre-tax earnings for the quarter were compared to for the prior year quarter, an increase of 131%.
Adjusted net earnings for the quarter were compared to net earnings of for the prior year quarter. Adjusted diluted earnings per share was compared to diluted earnings per share of in the prior year quarter. Adjusted EBITDA for the quarter was compared to for the prior year quarter.
See below for a reconciliation of these non-GAAP measures to the most comparable GAAP measures. The Company's order backlog was on , incr.
